Valuation Virbac

Stocks

Market Closed - Euronext Paris Other stock markets 01:55:00 25/07/26 am AEST			After hours 05:59:59 am
332.00 ^EUR	-0.75%		331.50	-0.15%

22/07	Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3
21/07	Despite the escalation in the Middle East, European stocks stay the course

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,584	1,927	3,035	2,651	2,995	2,802	-	-
Change	-	-46.24%	57.52%	-12.67%	13%	-6.43%	-	-
Enterprise Value (EV) ¹	3,510	1,848	2,983	2,819	3,168	2,929	2,878	2,761
Change	-	-47.37%	61.45%	-5.49%	12.37%	-7.54%	-1.76%	-4.05%
P/E	31.7x	15.8x	25x	18.3x	19.9x	16.4x	14.8x	13.5x
PBR	4.95x	2.29x	3.34x	2.54x	2.66x	2.2x	1.94x	1.72x
PEG	-	2.06x	-72.15x	0.9x	5.23x	1.2x	1.4x	1.39x
Capitalization / Revenue	3.37x	1.58x	2.43x	1.9x	2.04x	1.81x	1.7x	1.62x
EV / Revenue	3.3x	1.52x	2.39x	2.02x	2.16x	1.89x	1.75x	1.59x
EV / EBITDA	16.3x	8.27x	12.8x	9.96x	10.9x	9.3x	8.33x	7.4x
EV / EBIT	20.8x	10.1x	16.1x	12.4x	13.8x	11.5x	10.4x	9.11x
EV / FCF	36.5x	40.7x	50.8x	22.8x	29.7x	34.6x	24x	18.6x
FCF Yield	2.74%	2.46%	1.97%	4.39%	3.37%	2.89%	4.17%	5.36%
Dividend per Share ²	1.25	1.32	1.32	1.45	1.45	1.724	2.044	2.383
Rate of return	0.29%	0.58%	0.37%	0.46%	0.41%	0.52%	0.61%	0.71%
EPS ²	13.4	14.43	14.38	17.34	18	20.38	22.58	24.77
Distribution rate	9.33%	9.15%	9.18%	8.36%	8.06%	8.46%	9.05%	9.62%
Net sales ¹	1,064	1,216	1,247	1,397	1,465	1,550	1,647	1,733
EBITDA ¹	215.1	223.4	232.8	283	289.5	314.9	345.3	373
EBIT ¹	168.9	182.8	184.9	227.5	229.7	254	278	303.2
Net income ¹	113.2	122	121.3	145.3	150.9	171.1	189.9	208.8
Net Debt ¹	-73.83	-79.36	-52.36	168.5	172.8	126.7	75.16	-41.24
Reference price ²	424.50	228.00	359.50	316.50	357.50	334.50	334.50	334.50
Nbr of stocks (in thousands)	8,443	8,451	8,443	8,375	8,378	8,378	-	-
Announcement Date	22/3/22	23/3/23	19/3/24	13/3/25	17/3/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VIRBAC	16.41x	1.89x	9.3x	0.52%	3.19B
ZOETIS INC.	11.67x	3.89x	8.9x	2.88%	31.26B
ELANCO ANIMAL HEALTH INCORPORATED	252.86x	3.04x	15.32x	-.--%	12.38B
BLUESTAR ADISSEO COMPANY	7.66x	1.1x	4.06x	3.43%	3.78B
VIMIAN GROUP AB	32.83x	3.77x	13.45x	-.--%	1.81B
JINYU BIO-TECHNOLOGY CO., LTD.	48.9x	-	-	0.74%	1.86B
PHIBRO ANIMAL HEALTH CORPORATION	13.75x	1.29x	7.65x	1.4%	1.38B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	16.48x	2.08x	9.58x	1.87%	1.08B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	32.35x	-	-	0.46%	975M
VETOQUINOL SA	14.95x	1.06x	5.02x	1.31%	936M
Average	44.79x	2.26x	9.16x	1.26%	5.87B
Weighted average by Cap.	64.93x	3.25x	10.08x	1.91%